Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Discovery Labs Inc (DSCO)

Discovery Labs Inc (DSCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Discovery Labs Inc 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976-3622

www.discoverylabs.com P: 215-488-9300

Description:

Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals. The second compound under development is SuperVent, which is intended to treat airway diseases such as cystic fibrosis (CF) and chronic bronchitis.

Key Statistics

Overview:

Market Capitalization, $K 31,620
Shares Outstanding, K 8,150
Annual Sales, $ 990 K
Annual Net Income, $ -55,170 K
Last Quarter Sales, $ 660 K
Last Quarter Net Income, $ -10,110 K
60-Month Beta 1.65
% of Insider Shareholders 3.28%

Growth:

1-Year Return -77.68%
3-Year Return -85.47%
5-Year Return -87.31%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -73.04%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/05/16
Earnings Per Share ttm -6.30
EPS Growth vs. Prev Qtr 0.04%
EPS Growth vs. Prev Year 47.08%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-14 on 01/22/16

DSCO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -562.15%
Return-on-Assets % -106.26%
Profit Margin % -5,572.73%
Debt/Equity 3.02
Price/Sales 17.70
Price/Cash Flow N/A
Price/Book 3.45
Book Value/Share 1.01
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar